Mapping and evaluation of global and country-specific cardiovascular disease risk prediction models

Samina Akhtar1, Zainab Samad1, Gerald S Bloomfield2

  • 1Department of Medicine, Aga Khan University, Karachi, Pakistan.

Future Cardiology
|March 17, 2026
PubMed

Insights

Cardiovascular disease (CVD) risk models vary in accuracy across populations. Developing locally validated, population-specific models is crucial for equitable CVD risk assessment and prevention worldwide.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a major global health burden.
  • Accurate CVD risk prediction is essential for effective prevention strategies.
  • Existing risk models show variable performance across diverse populations.

Purpose of the Study:

  • To systematically review and evaluate global and country-specific CVD risk prediction models.
  • To identify strengths, limitations, and applicability of current models.
  • To inform future development of more accurate and equitable risk assessment tools.

Main Methods:

  • A comprehensive literature search was performed using PubMed and Google Scholar.
  • Thirty relevant studies detailing CVD risk prediction models were selected and analyzed.
  • Models were evaluated based on their risk factors, discrimination (C-statistics), and validation across different cohorts.

Main Results:

  • Most CVD risk models utilize traditional factors like age, sex, blood pressure, cholesterol, and smoking.
  • Discrimination (C-statistics 0.66–0.80) and validation were moderate to good, but applicability varied.
  • Global models like WHO/ISH and Globorisk offer regional calibration; country-specific models showed superior performance due to local data integration.

Conclusions:

  • Existing CVD risk models face challenges with population variability, underrepresentation of certain groups, and exclusion of novel risk factors.
  • Country-specific and regionally calibrated models demonstrate better performance than generic global models.
  • Future research should focus on developing and validating localized, population-specific CVD risk models for equitable global health outcomes.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
727
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K